VH3-53/66-Class RBD-Specific Human Monoclonal Antibody iB20 Displays Cross-Neutralizing Activity against Emerging SARS-CoV-2 Lineages
Note: employees of the Institute are marked with an asterisk (*) in the list of authors.
Web of Science ,
Scopus
Authors
Kulemzin S.V, * Sergeeva M.V., Baranov K.O., Gorchakov A.A., Guselnikov S.V., Belovezhets T.N., Volkova O.Yu., Najakshin A.M., Chikaev N.A., * Danilenko D.M., Taranin A.V.
Publication type
Journal article
Indexed in
Web of Science ,
Scopus Info:
Published in
Journal of Personalized Medicine
Year of publication
2022
Volume
12
Number
6
Pages
895